Return to homepagePandemic Pact

Cube Dx GmbH

  • Funded by Austrian Research Promotion Agency (FFG)
  • Total publications:0 publications

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    N/A

  • Funder

    Austrian Research Promotion Agency (FFG)

  • Research Location

    Austria

  • Lead Research Institution

    Cube Dx GmbH

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Diagnostics

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

SCREPA - Broad and Efficient Screening of Respiratory Pathogens including SARS-Cov-2. Cube Dx is developing a test to screen more than 20 of the most dangerous respiratory pathogens in parallel - including SARS-Cov-2. The high throughput of the test enables a quick clarification and thus rapid targeted therapy.